Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry

Matthew Waas, Ranjuna Weerasekera, Erin M. Kropp, Marisol Romero-Tejeda, Ellen N. Poon, Kenneth R. Boheler, Paul W. Burridge, Rebekah L. Gundry

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Several protocols now support efficient differentiation of human pluripotent stem cells to cardiomyocytes (hPSC-CMs) but these still indicate line-to-line variability. As the number of studies implementing this technology expands, accurate assessment of cell identity is paramount to well-defined studies that can be replicated among laboratories. While flow cytometry is apt for routine assessment, a standardized protocol for assessing cardiomyocyte identity has not yet been established. Therefore, the current study leveraged targeted mass spectrometry to confirm the presence of troponin proteins in day 25 hPSC-CMs and systematically evaluated multiple anti-troponin antibodies and sample preparation protocols for their suitability in assessing cardiomyocyte identity. Results demonstrate challenges to interpreting data generated by published methods and inform the development of a robust protocol for routine assessment of hPSC-CMs. The data, workflow for antibody evaluation, and standardized protocol described here should benefit investigators new to this field and those with expertise in hPSC-CM differentiation.

Original languageEnglish (US)
Pages (from-to)395-410
Number of pages16
JournalStem Cell Reports
Volume12
Issue number2
DOIs
StatePublished - Feb 12 2019

Fingerprint

Flow cytometry
Stem cells
Cardiac Myocytes
Flow Cytometry
Troponin
Pluripotent Stem Cells
Antibodies
Mass spectrometry
Workflow
Anti-Idiotypic Antibodies
Mass Spectrometry
Research Personnel
Proteins
Technology

Keywords

  • cardiomyocytes
  • flow cytometry
  • mass spectrometry
  • quality control
  • standard operating protocol
  • troponin

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Developmental Biology
  • Cell Biology

Cite this

Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry. / Waas, Matthew; Weerasekera, Ranjuna; Kropp, Erin M.; Romero-Tejeda, Marisol; Poon, Ellen N.; Boheler, Kenneth R.; Burridge, Paul W.; Gundry, Rebekah L.

In: Stem Cell Reports, Vol. 12, No. 2, 12.02.2019, p. 395-410.

Research output: Contribution to journalArticle

Waas, Matthew ; Weerasekera, Ranjuna ; Kropp, Erin M. ; Romero-Tejeda, Marisol ; Poon, Ellen N. ; Boheler, Kenneth R. ; Burridge, Paul W. ; Gundry, Rebekah L. / Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry. In: Stem Cell Reports. 2019 ; Vol. 12, No. 2. pp. 395-410.
@article{b03b0cb3a34147efa8e095d166fa79f5,
title = "Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry",
abstract = "Several protocols now support efficient differentiation of human pluripotent stem cells to cardiomyocytes (hPSC-CMs) but these still indicate line-to-line variability. As the number of studies implementing this technology expands, accurate assessment of cell identity is paramount to well-defined studies that can be replicated among laboratories. While flow cytometry is apt for routine assessment, a standardized protocol for assessing cardiomyocyte identity has not yet been established. Therefore, the current study leveraged targeted mass spectrometry to confirm the presence of troponin proteins in day 25 hPSC-CMs and systematically evaluated multiple anti-troponin antibodies and sample preparation protocols for their suitability in assessing cardiomyocyte identity. Results demonstrate challenges to interpreting data generated by published methods and inform the development of a robust protocol for routine assessment of hPSC-CMs. The data, workflow for antibody evaluation, and standardized protocol described here should benefit investigators new to this field and those with expertise in hPSC-CM differentiation.",
keywords = "cardiomyocytes, flow cytometry, mass spectrometry, quality control, standard operating protocol, troponin",
author = "Matthew Waas and Ranjuna Weerasekera and Kropp, {Erin M.} and Marisol Romero-Tejeda and Poon, {Ellen N.} and Boheler, {Kenneth R.} and Burridge, {Paul W.} and Gundry, {Rebekah L.}",
year = "2019",
month = "2",
day = "12",
doi = "10.1016/j.stemcr.2018.12.016",
language = "English (US)",
volume = "12",
pages = "395--410",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry

AU - Waas, Matthew

AU - Weerasekera, Ranjuna

AU - Kropp, Erin M.

AU - Romero-Tejeda, Marisol

AU - Poon, Ellen N.

AU - Boheler, Kenneth R.

AU - Burridge, Paul W.

AU - Gundry, Rebekah L.

PY - 2019/2/12

Y1 - 2019/2/12

N2 - Several protocols now support efficient differentiation of human pluripotent stem cells to cardiomyocytes (hPSC-CMs) but these still indicate line-to-line variability. As the number of studies implementing this technology expands, accurate assessment of cell identity is paramount to well-defined studies that can be replicated among laboratories. While flow cytometry is apt for routine assessment, a standardized protocol for assessing cardiomyocyte identity has not yet been established. Therefore, the current study leveraged targeted mass spectrometry to confirm the presence of troponin proteins in day 25 hPSC-CMs and systematically evaluated multiple anti-troponin antibodies and sample preparation protocols for their suitability in assessing cardiomyocyte identity. Results demonstrate challenges to interpreting data generated by published methods and inform the development of a robust protocol for routine assessment of hPSC-CMs. The data, workflow for antibody evaluation, and standardized protocol described here should benefit investigators new to this field and those with expertise in hPSC-CM differentiation.

AB - Several protocols now support efficient differentiation of human pluripotent stem cells to cardiomyocytes (hPSC-CMs) but these still indicate line-to-line variability. As the number of studies implementing this technology expands, accurate assessment of cell identity is paramount to well-defined studies that can be replicated among laboratories. While flow cytometry is apt for routine assessment, a standardized protocol for assessing cardiomyocyte identity has not yet been established. Therefore, the current study leveraged targeted mass spectrometry to confirm the presence of troponin proteins in day 25 hPSC-CMs and systematically evaluated multiple anti-troponin antibodies and sample preparation protocols for their suitability in assessing cardiomyocyte identity. Results demonstrate challenges to interpreting data generated by published methods and inform the development of a robust protocol for routine assessment of hPSC-CMs. The data, workflow for antibody evaluation, and standardized protocol described here should benefit investigators new to this field and those with expertise in hPSC-CM differentiation.

KW - cardiomyocytes

KW - flow cytometry

KW - mass spectrometry

KW - quality control

KW - standard operating protocol

KW - troponin

UR - http://www.scopus.com/inward/record.url?scp=85061062395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061062395&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2018.12.016

DO - 10.1016/j.stemcr.2018.12.016

M3 - Article

C2 - 30686762

AN - SCOPUS:85061062395

VL - 12

SP - 395

EP - 410

JO - Stem Cell Reports

JF - Stem Cell Reports

SN - 2213-6711

IS - 2

ER -